<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13</volume><submitter>Pearce A</submitter><pubmed_abstract>Signalling of the calcitonin-like receptor (CLR) is multifaceted, due to its interaction with receptor activity modifying proteins (RAMPs), and three endogenous peptide agonists. Previous studies have focused on the bias of G protein signalling mediated by the receptor and receptor internalisation of the CLR-RAMP complex has been assumed to follow the same pattern as other Class B1 G Protein-Coupled Receptors (GPCRs). Here we sought to measure desensitisation of the three CLR-RAMP complexes in response to the three peptide agonists, through the measurement of β-arrestin recruitment and internalisation. We then delved further into the mechanism of desensitisation through modulation of β-arrestin activity and the expression of GPCR kinases (GRKs), a key component of homologous GPCR desensitisation. First, we have shown that CLR-RAMP1 is capable of potently recruiting β-arrestin1 and 2, subsequently undergoing rapid endocytosis, and that CLR-RAMP2 and -RAMP3 also utilise these pathways, although to a lesser extent. Following this we have shown that agonist-dependent internalisation of CLR is β-arrestin dependent, but not required for full agonism. Overexpression of GRK2-6 was then found to decrease receptor signalling, due to an agonist-independent reduction in surface expression of the CLR-RAMP complex. These results represent the first systematic analysis of the importance of β-arrestins and GRKs in CLR-RAMP signal transduction and pave the way for further investigation regarding other Class B1 GPCRs.</pubmed_abstract><journal>Frontiers in physiology</journal><pagination>840763</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9001978</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Determining the Effects of Differential Expression of GRKs and β-arrestins on CLR-RAMP Agonist Bias.</pubmed_title><pmcid>PMC9001978</pmcid><pubmed_authors>Redfern-Nichols T</pubmed_authors><pubmed_authors>Harris M</pubmed_authors><pubmed_authors>Poyner DR</pubmed_authors><pubmed_authors>Ladds G</pubmed_authors><pubmed_authors>Pearce A</pubmed_authors><pubmed_authors>Wigglesworth M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Determining the Effects of Differential Expression of GRKs and β-arrestins on CLR-RAMP Agonist Bias.</name><description>Signalling of the calcitonin-like receptor (CLR) is multifaceted, due to its interaction with receptor activity modifying proteins (RAMPs), and three endogenous peptide agonists. Previous studies have focused on the bias of G protein signalling mediated by the receptor and receptor internalisation of the CLR-RAMP complex has been assumed to follow the same pattern as other Class B1 G Protein-Coupled Receptors (GPCRs). Here we sought to measure desensitisation of the three CLR-RAMP complexes in response to the three peptide agonists, through the measurement of β-arrestin recruitment and internalisation. We then delved further into the mechanism of desensitisation through modulation of β-arrestin activity and the expression of GPCR kinases (GRKs), a key component of homologous GPCR desensitisation. First, we have shown that CLR-RAMP1 is capable of potently recruiting β-arrestin1 and 2, subsequently undergoing rapid endocytosis, and that CLR-RAMP2 and -RAMP3 also utilise these pathways, although to a lesser extent. Following this we have shown that agonist-dependent internalisation of CLR is β-arrestin dependent, but not required for full agonism. Overexpression of GRK2-6 was then found to decrease receptor signalling, due to an agonist-independent reduction in surface expression of the CLR-RAMP complex. These results represent the first systematic analysis of the importance of β-arrestins and GRKs in CLR-RAMP signal transduction and pave the way for further investigation regarding other Class B1 GPCRs.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-22T19:43:56.974Z</modification><creation>2025-04-06T02:54:39.041Z</creation></dates><accession>S-EPMC9001978</accession><cross_references><pubmed>35422711</pubmed><doi>10.3389/fphys.2022.840763</doi></cross_references></HashMap>